4//SEC Filing
Lwee Frederick 4
Accession 0001181431-10-010753
CIK 0001282393other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 8:19 PM ET
Size
15.7 KB
Accession
0001181431-10-010753
Insider Transaction Report
Form 4
Lwee Frederick
Principal Financial Officer
Transactions
- Disposition to Issuer
Employee Stock Option (Right to Buy)
2010-02-16−40,000→ 0 totalExercise: $2.76Exp: 2019-09-02→ Common Stock (40,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2010-02-16−90,000→ 0 totalExercise: $1.80Exp: 2018-11-04→ Common Stock (90,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2010-02-16−10,000→ 0 totalExercise: $1.12Exp: 2019-01-22→ Common Stock (10,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2010-02-16−44,000→ 0 totalExercise: $1.18Exp: 2019-04-08→ Common Stock (44,000 underlying)
Footnotes (5)
- [F1]Vine Acquisition Corp. (the "Purchaser"), initiated a tender offer pursuant to Purchaser's offer to purchase all of the outstanding shares of BioForm Medical, Inc. (the "Issuer") at a cash purchase price of $5.45 per share, without interest thereon, and less any applicable withholding taxes, subject to the terms described in the Offer to Purchase filed with the Securities and Exchange Commission on January 15, 2010 (the "Tender Offer") and the Agreement and Plan of Merger, dated as of December 31, 2009, by and among Merz GmbH & Co. KGaA, the Purchaser and the Issuer. On the date of grant, the shares underlying this option were to vest and become exercisable as to 1/4 of the shares on 09/02/2010 and quarterly vesting thereafter, with options being fully vested five years following the date of grant. (Continued in footnote 2).
- [F2]The shares underlying this option, which were unvested at the closing of the Tender Offer, were canceled at the closing of the Tender Offer in exchange for the right to receive cash payment(s) representing the number of shares of Issuer's common stock underlying such options multiplied by $5.45, less the aggregate exercise price of the options, upon the date(s) the shares underlying this option would have otherwise become vested.
- [F3]On the date of grant, the shares underlying this option were to vest and become exercisable as to 1/48 of the shares on 12/04/2008 and monthly thereof. 28,125 of the shares underlying these options, which were vested at the closing of the Tender Offer, were canceled at the closing of the Tender Offer in exchange for a cash payment of $102,656.25 representing the number of vested shares of Issuer's common stock underlying such options multiplied by $5.45, less the aggregate exercise price of the options. The remaining shares underlying these options, which were unvested at the closing of the Tender Offer, were canceled at the closing of the Tender Offer in exchange for the right to receive cash payment(s) representing the number of shares of Issuer's common stock underlying such options multiplied by $5.45, less the aggregate exercise price of the options, upon the date(s) the shares underlying this option would have otherwise become vested.
- [F4]On the date of grant, the shares underlying this option were to vest and become exercisable as to 1/4 of the shares on 01/22/2010 and each anniversary thereof. 2,500 of the shares underlying these options, which were vested at the closing of the Tender Offer, were canceled at the closing of the Tender Offer in exchange for a cash payment of $10,825.00 representing the number of vested shares of Issuer's common stock underlying such options multiplied by $5.45, less the aggregate exercise price of the options. The remaining shares underlying these options, which were unvested at the closing of the Tender Offer, were canceled at the closing of the Tender Offer in exchange for the right to receive cash payment(s) representing the number of shares of Issuer's common stock underlying such options multiplied by $5.45, less the aggregate exercise price of the options, upon the date(s) the shares underlying this option would have otherwise become vested.
- [F5]On the date of grant, the shares underlying this option were to vest and become exercisable as to 1/4 of the shares on 04/08/2010 and quarterly vesting thereafter, with options being fully vested four years following the date of grant. The shares underlying this option, which were unvested at the closing of the Tender Offer, were canceled at the closing of the Tender Offer in exchange for the right to receive cash payment(s) representing the number of shares of Issuer's common stock underlying such options multiplied by $5.45, less the aggregate exercise price of the options, upon the date(s) the shares underlying this option would have otherwise become vested.
Documents
Issuer
BIOFORM MEDICAL INC
CIK 0001282393
Entity typeother
Related Parties
1- filerCIK 0001463501
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 8:19 PM ET
- Size
- 15.7 KB